More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Blocking Solution with Donkey Serum (ready to use)

Blocking Solution with Donkey Serum (ready to use)

Research Use Only
GTX30972
GeneTex
DownloadDatasheet
Product group Chemicals
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    Blocking Solution with Donkey Serum (ready to use)
  • Delivery Days Customer
    9
  • Application Supplier Note
    The serum used to make this blocking solution is obtained from pools of healthy adult animals. The serum is heat inactivated at 56C for 60 minutes and dilpidated and filtered. The serum is tested with appropriate biotinylated antibody for cross-reactivity. Immuno protein blocking solutions is ready to use and do not contain azide or phosphate buffers.
  • Certification
    Research Use Only
  • Formulation
    Liquid
  • Scientific Description
    Blocking Solution with Donkey Serum (ready to use) contains 5% serum in tris buffered saline with 0.05% proclin 300 as preservative.
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12161700

References

  • KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinsons Disease. Nam MH et al., 2021 Jul, Neurotherapeutics
    Read more
  • Osteoblast-activating peptide exhibits a specific distribution pattern in mouse ovary and may regulate ovarian steroids and local calcium levels. Noreldin AE et al., 2021, Am J Transl Res
    Read more
  • Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinsons Disease. An H et al., 2021 Jun 30, Exp Neurobiol
    Read more
  • Circadian clock genes and respiratory neuroplasticity genes oscillate in the phrenic motor system. Kelly MN et al., 2020 Jun 1, Am J Physiol Regul Integr Comp Physiol
    Read more
  • Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinsons Disease. Heo JY et al., 2020 Jan 20, Curr Biol
    Read more
  • Notch Signaling Regulates MMP-13 Expression via Runx2 in Chondrocytes. Xiao D et al., 2019 Oct 30, Sci Rep
    Read more
  • Immunohistochemical localization of osteoblast activating peptide in the mouse kidney. Noreldin AE et al., 2018 May, Acta Histochem
    Read more
  • Effects of transforming growth factor-beta1 treatment on muscle regeneration and adipogenesis in glycerol-injured muscle. Mahdy MAA et al., 2017 Nov, Anim Sci J
    Read more